ERBB3 and melanoma: Importantly, the cell-killing effects of fucoidan could be enhanced by inhibiting ERBB3 with either a specific shRNA or a novel, selective ERBB3 neutralizing antibody, underscoring the pivotal role played by this receptor in melanoma [28].